Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia A Beaver

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Oncology (Williston Park, N.Y.)|November 18, 2015
Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory PerspectivesLaleh Amiri-Kordestani, Julia A Beaver, Patricia Cortazar
JAMA Oncology|July 15, 2021
Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug DevelopmentLola Fashoyin-Aje, Julia A Beaver, Richard Pazdur
The New England Journal of Medicine|June 28, 2018
Metastasis-free Survival - A New End Point in Prostate Cancer TrialsJulia A Beaver, Paul G Kluetz, Richard Pazdur
Breast Cancer Research : BCR|February 22, 2013
Needles in a haystack: finding recurrent genomic changes in breast cancerJustin Cidado, Julia A Beaver, Ben Ho Park
Clinical Pharmacology and Therapeutics|July 9, 2020
Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future DirectionsNam Atiqur Rahman, Gwynn Ison, Julia A Beaver
Advances in Experimental Medicine and Biology|March 19, 2016
Circulating Plasma Tumor DNAHeather A Parsons, Julia A Beaver, Ben H Park
Journal of Geriatric Oncology|December 27, 2016
Enrollment of older adults on oncology trials: An FDA perspectiveHarpreet Singh, Julia A Beaver, Geoffrey Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Continuation of Third-Generation Tyrosine Kinase Inhibitors in Second-Line Trials for Bernardo H L Goulart, Erin Larkins, Julia A Beaver, et al.
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy - Authors' replyJennifer J Gao, Joyce Cheng, Julia A Beaver, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Strategies to Maximize Patient Participation in Clinical TrialsEric H Rubin, Mary J Scroggins, Kirsten B Goldberg, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Oncology (Williston Park, N.Y.)|November 18, 2015
Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory PerspectivesLaleh Amiri-Kordestani, Julia A Beaver, Patricia Cortazar
JAMA Oncology|July 15, 2021
Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug DevelopmentLola Fashoyin-Aje, Julia A Beaver, Richard Pazdur
The New England Journal of Medicine|June 28, 2018
Metastasis-free Survival - A New End Point in Prostate Cancer TrialsJulia A Beaver, Paul G Kluetz, Richard Pazdur
Breast Cancer Research : BCR|February 22, 2013
Needles in a haystack: finding recurrent genomic changes in breast cancerJustin Cidado, Julia A Beaver, Ben Ho Park
Clinical Pharmacology and Therapeutics|July 9, 2020
Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future DirectionsNam Atiqur Rahman, Gwynn Ison, Julia A Beaver
Advances in Experimental Medicine and Biology|March 19, 2016
Circulating Plasma Tumor DNAHeather A Parsons, Julia A Beaver, Ben H Park
Journal of Geriatric Oncology|December 27, 2016
Enrollment of older adults on oncology trials: An FDA perspectiveHarpreet Singh, Julia A Beaver, Geoffrey Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Continuation of Third-Generation Tyrosine Kinase Inhibitors in Second-Line Trials for Bernardo H L Goulart, Erin Larkins, Julia A Beaver, et al.
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy - Authors' replyJennifer J Gao, Joyce Cheng, Julia A Beaver, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Strategies to Maximize Patient Participation in Clinical TrialsEric H Rubin, Mary J Scroggins, Kirsten B Goldberg, et al.
Pageof 15